• Chapter 1 | The Continuum of Heart Failure: Classifying Heart Failure Listen to 2 key experts as they review the types, classification, and pathophysiology of heart failure. • Chapter 2 | The Continuum of Heart Failure: The Interconnected Nature of the Cardio-Renal-Metabolic (CRM) Systems The cardiovascular, renal, and metabolic systems are interconnected. Listen as Melissa Magwire, RN,MSN,CDE and James O’Keefe, MD discuss how these three systems impact each other, and the effect that these connections have on patients with heart failure. • Chapter 3 | The Continuum of Heart Failure: Heart Failure and Type 2 Diabetes: Assessment of Patient Care Listen as Melissa Magwire, RN,MSN,CDE and James O’Keefe, MD explore the link between heart failure and diabetes through a patient case. This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.

Pri-Med strives to make it easier for you to keep up with the latest medical knowledge. Learn more about how our focus starts with you.

In this podcast, cardiologist Ty Gluckman will take a deep dive into the cardiology benefits of glucagon like peptide-1 receptor agonists (GLP-1 RA). He will review the clinical trial data which has resulted in GLP-1 RA incorporation into guidelines, which address patients who have both diabetes and atherosclerotic cardiovascular disease. Dr. Gluckman will bring the perspective of a cardiologist into the discussion of these agents with emerging significance in cardiovascular risk reduction.

With the growing role of GLP-1 RAs in the management of diabetes, primary care providers are likely to find themselves discussing this class of medications with their patients. In this podcast, Dr. Michelle Magee will focus on barriers that patients may face to starting a GLP-1 RA and common questions that emerge in patient teaching. Faculty will review ways to troubleshoot these challenges and empower the clinician to engage in effective dialogue around this drug class. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/18/2020 and they are subject to change as new information is published.

This podcast series will provide you with on the go learning covering the key points about GLP-1 receptor agonists (GLP-1 RAs). Dr. Michelle Magee will focus on barriers that patients may face to starting a GLP-1 RA and common questions that emerge in patient teaching. Cardiologist Ty Gluckman will take a deep dive into the cardiology benefits and indications for GLP-1 RAs. A FAQ session with Dr. Richard Pratley will answer Pri-Med learner questions about GLP-1 RAs.

In this podcast, Dr. Richard Pratley will answer Pri-Med learner questions submitted during recent CME sessions focusing on glucagon like peptide-1 receptor agonists (GLP-1 RAs). Join us for expert answers to questions about who can benefit from GLP-1 RAs, the safety of these medications in different populations, and much more. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/10/2020 and they are subject to change as new information is published.